Phibro Animal Health Corporation

DB:PB8 Stock Report

Market Cap: €828.8m

Phibro Animal Health Past Earnings Performance

Past criteria checks 0/6

Phibro Animal Health's earnings have been declining at an average annual rate of -17.2%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 5.9% per year. Phibro Animal Health's return on equity is 6.7%, and it has net margins of 1.7%.

Key information

-17.2%

Earnings growth rate

-17.2%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate5.9%
Return on equity6.7%
Net Margin1.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Phibro Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:PB8 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,0471721229
30 Jun 241,018221829
31 Mar 241,000132400
31 Dec 23982152380
30 Sep 239772120624
30 Jun 239783319224
31 Mar 23978292200
31 Dec 22972362150
30 Sep 22960462090
30 Jun 229424918421
31 Mar 22907592010
31 Dec 21879531990
30 Sep 21853491980
30 Jun 21833541940
31 Mar 21799431910
31 Dec 20798441900
30 Sep 20806431910
30 Jun 20800341900
31 Mar 20818371920
31 Dec 19813381850
30 Sep 19818411800
30 Jun 19828551760
31 Mar 19836681680
31 Dec 18839731720
30 Sep 18827651700
30 Jun 18820651670
31 Mar 18803581670
31 Dec 17784621610
30 Sep 17770681580
30 Jun 17764651530
31 Mar 17759641530
31 Dec 16752591520
30 Sep 16752761520
30 Jun 16752831510
31 Mar 16747781530
31 Dec 15751761520
30 Sep 15748601480
30 Jun 15749601450
31 Mar 15747321400
31 Dec 14733221380
30 Sep 14717101360
30 Jun 14692-31350
31 Mar 14672201227

Quality Earnings: PB8 has a large one-off loss of $9.5M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: PB8's current net profit margins (1.7%) are lower than last year (2.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PB8's earnings have declined by 17.2% per year over the past 5 years.

Accelerating Growth: PB8's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PB8 had negative earnings growth (-16.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (25.4%).

Return on Equity

High ROE: PB8's Return on Equity (6.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 12:21
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Phibro Animal Health Corporation is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Balaji PrasadBarclays
Matthew KornBarclays
Douglas TsaoBarclays